SCHEMBL1417120

SCHEMBL1417120

FC(F)(F)c1cccnc1Oc1cc(Br)cc(Br)c1

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ ATM Q13315 1/20 0.51
▸ DRD1 P21728 3/20 0.45
▸ KCNH2 Q12809 2/20 0.44
▸ SCN9A Q15858 2/20 0.44
▸ CSNK1A1 P48729 1/20 0.42
▸ CSNK1D P48730 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ CSNK1G2 P78368 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ FPR2 P25090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8129823 0.80 ALDH1A1 (0.59) ALDH1A1MAPTATMDRD1SCN9A
SCHEMBL9338866 0.76 ALDH1A1 (0.59) ALDH1A1MAPTATMDRD1KCNH2
SCHEMBL11187255 0.76 ALDH1A1 (0.59) ALDH1A1MAPTATMDRD1SCN9A
SCHEMBL8237109 0.76 ALDH1A1 (0.59) ALDH1A1MAPTATMDRD1KCNH2
SCHEMBL7898118 0.76 ALDH1A1 (0.59) ALDH1A1MAPTATMDRD1SCN9A
SCHEMBL15307367 0.73 MAPT (0.55) ALDH1A1MAPTATMDRD1KCNH2
SCHEMBL29716239 0.72 KMT2A (0.40) ALDH1A1DRD1
SCHEMBL22009635 0.72 KMT2A (0.40) ALDH1A1DRD1
SCHEMBL4318313 0.72 ALDH1A1 (0.54) ALDH1A1MAPTATMDRD1SCN9A
SCHEMBL2486479 0.72 CSNK1A1 (0.54) ALDH1A1MAPTATMKCNH2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426473-B2 Phenoxy acetic acids as PPAR delta activators High Point Pharnaceuticals, LLC (US) 2013-04-23 — — US disclosed
US-20120232080-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS HIGH POINT PHARMACEUTICALS, LLC (US) 2012-09-13 — — US disclosed
US-8217086-B2 Phenoxy acetic acids as PPAR delta activators HIGH POINT PHARMACEUTICALS, LLC (US) 2012-07-10 — — US disclosed
EP-1899302-B1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS HIGH POINT PHARMACEUTICALS LLC (US) 2011-10-19 — — EP disclosed
US-20110183982-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS HIGH POINT PHARMACEUTICALS, LLC (US) 2011-07-28 — — US disclosed
US-7943669-B2 Phenoxy acetic acids as PPAR delta activators HIGH POINT PHARMACEUTICALS, LLC (US) 2011-05-17 — — US disclosed
EP-2298742-A1 Phenoxy acetic acids as PPAR delta activators High Point Pharmaceuticals, LLC (US) 2011-03-23 — — EP disclosed
US-20090192162-A1 Phenoxy Acetic Acids as PPAR Delta Activators TRANSTECH PHARMA, INC. (NC) 2009-07-30 — — US disclosed
EP-1899302-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS Novo Nordisk A/S (DK) 2008-03-19 — — EP disclosed
WO-2007003581-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS NOVO NORDISK A/S (DK) 2007-01-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192162-A1 Phenoxy Acetic Acids as PPAR Delta Activators PPARA, PPARG, PPARD ALDH1A1 159/4885MAPT 2797/4885ATM 3569/4885
US-20120232080-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS PPARA, PPARG, PPARD ALDH1A1 159/4885MAPT 2797/4885ATM 3569/4885
US-20110183982-A1 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS PPARA, PPARG, PPARD ALDH1A1 159/4885MAPT 2797/4885ATM 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback